Chlordiazepoxide and Amitriptyline Hydrochloride Tablets
» Chlordiazepoxide and Amitriptyline Hydrochloride Tablets contain not less than 90.0 percent and not more than 110.0 percent of the labeled amount of chlordiazepoxide (C16H14ClN3O) and an amount of amitriptyline hydrochloride equivalent to not less than 90.0 percent and not more than 110.0 percent of the labeled amount of amitriptyline (C20H23N).
Packaging and storage Preserve in tight, light-resistant containers.
USP Reference standards 11
Identification The retention times of the major peaks in the chromatogram of the Assay preparation are the same as those of the Standard preparation as obtained in the Assay.
Medium: simulated gastric fluid TS, prepared without pepsin; 900 mL.
Apparatus 1: 100 rpm.
Time: 30 minutes.
Procedure Determine the absorbances of filtered portions of the solution under test, suitably diluted with Dissolution Medium, if necessary, and Standard solutions having known concentrations of USP Chlordiazepoxide RS and USP Amitriptyline Hydrochloride RS in the same Medium, at wavelengths of 239 nm and 309 nm, using Dissolution Medium as the blank. Calculate the percentage of chlordiazepoxide (C16H14ClN3O) dissolved by the formula:
100(CD / L)(AU / AS)in which C is the concentration, in mg per mL, of USP Chlordiazepoxide RS in the Standard solution determined at the wavelength of 309 nm; D is the dilution factor of the diluted solution under test; L is the labeled amount, in mg, of chlordiazepoxide in each Tablet; and AU and AS are the absorbances of the solution under test and the chlordiazepoxide Standard solution, respectively, at the wavelength of 309 nm.
Calculate the percentage of amitriptyline (C20H23N) dissolved by the formula:
100(277.40/313.86)(CD / L)(AX / AS)
in which 277.40 and 313.86 are the molecular weights of amitriptyline and amitriptyline hydrochloride, respectively; C is the concentration, in mg per mL, of USP Amitriptyline Hydrochloride RS in the amitriptyline Standard solution; D is the dilution factor of the diluted solution under test; L is the labeled amount, in mg, of amitriptyline in each Tablet; AS is the absorbance of the amitriptyline Standard solution at the wavelength of 239 nm; and AX is defined by the formula:
AU239 AU309 (C309 AS239 / C239 AS309)
in which AU239 and AU309 are the absorbances of the solution under test measured at 239 nm and 309 nm, respectively; C309 and C239 are the concentrations, in mg per mL, of USP Chlordiazepoxide RS in the Standard solution obtained at wavelengths of 309 and 239 nm, respectively; and AS239 and AS309 are the absorbances of the chlordiazepoxide Standard solution determined at the wavelengths indicated in the subscripts. [noteAll of the chlordiazepoxide measurements may be made with either a single Standard solution or two separate Standard solutions. ]
Tolerances Not less than 85% (Q) of the labeled amount of chlordiazepoxide (C16H14ClN3O) and an amount of amitriptyline hydrochloride equivalent to not less than 85% (Q) of the labeled amount of amitriptyline (C20H23N) are dissolved in 30 minutes.
Uniformity of dosage units 905: meet the requirements for Content Uniformity with respect to chlordiazepoxide and to amitriptyline.
Related compounds Transfer an accurately weighed portion of finely powdered Tablets, equivalent to about 25 mg of chlordiazepoxide, to a 10-mL conical flask, add 2.5 mL of acetone, and shake. Allow any undissolved particles to settle, and apply 50 µL of the supernatant to a thin-layer chromatographic plate (see Chromatography 621), coated with a 0.25-mm layer of chromatographic silica gel. Apply to the same plate 20 µL of an acetone solution containing 1 mg per mL of USP Chlordiazepoxide Related Compound A RS and 10 µL of an acetone solution containing 50 µg per mL of USP 2-Amino-5-chlorobenzophenone RS. Develop the chromatogram in a chromatographic chamber (not previously saturated with the developing solvent) in ethyl acetate until the solvent front has moved about three-fourths of the length of the plate. Remove the plate from the developing chamber, mark the solvent front, and allow the solvent to evaporate. Locate the spots on the plate by lightly spraying with 2 N sulfuric acid, drying at 105 for 15 minutes, and then spraying in succession with sodium nitrite solution (1 in 1000), ammonium sulfamate solution (1 in 200), and N-(1-naphthyl)ethylenediamine dihydrochloride solution (1 in 1000): any spots from the test solution are not greater in size or intensity than the spots at the respective RF values produced by the Standard solutions, corresponding to not more than 4.0% of chlordiazepoxide related compound A, and not more than 0.1% of 2-amino-5-chlorobenzophenone.
Assay [noteUse low-actinic glassware in this procedure. ]
pH 2.5 Buffer Mix 10.5 mL of 0.20 N sodium hydroxide with 100 mL of a solution consisting of 0.04 M acetic acid, 0.04 M phosphoric acid, and 0.04 M boric acid (prepared by dissolving 2.402 g of glacial acetic acid, 4.612 g of phosphoric acid, and 2.473 g of boric acid in sufficient water to obtain 1000 mL of solution).
Solvent mixture Prepare a mixture consisting of pH 2.5 Buffer, tetrahydrofuran, and methanol (5:4:1).
Mobile phase Prepare a solution of 0.01 M sodium lauryl sulfate in Solvent mixture.
Standard preparation Dissolve accurately weighed quantities of USP Chlordiazepoxide RS and USP Amitriptyline Hydrochloride RS in Solvent mixture, and quantitatively dilute with Solvent mixture to obtain a solution having known concentrations of about 1 mg of USP Chlordiazepoxide RS per mL and about 2.8 mg of USP Amitriptyline Hydrochloride RS per mL. Transfer 10.0 mL of this solution to a 100-mL volumetric flask, dilute with Solvent mixture to volume, and mix.
Assay preparation Weigh and finely powder not fewer than 20 Tablets. Transfer an accurately weighed portion of the powder, equivalent to about 50 mg of chlordiazepoxide and about 125 mg of amitriptyline, to a 50-mL volumetric flask, add Solvent mixture to volume, sonicate to disperse the mixture, and allow undissolved particles to settle. Transfer 10.0 mL of the resulting solution to a 100-mL volumetric flask, dilute with Solvent mixture to volume, and mix. Pass a portion of this solution through a filter having a 5-µm or finer porosity, and use the filtrate as the Assay preparation.
Chromatographic system (see Chromatography 621) The chromatograph is equipped with a 254-nm detector and a 3.9-mm × 30-cm column that contains packing L1. The flow rate is about 1 mL per minute. Chromatograph the Standard preparation, and record the peak responses as directed for Procedure: the resolution, R, is not less than 2.0; and the relative standard deviation for replicate injections is not more than 2.0%.
Procedure Separately inject equal volumes (about 20 µL) of the Standard preparation and the Assay preparation into the chromatograph, and record the chromatogram. Measure the peak responses at approximate retention times of 5 minutes for chlordiazepoxide and 7 minutes for amitriptyline hydrochloride. Calculate the quantity, in mg, of chlordiazepoxide (C16H14ClN3O) in the portion of Tablets taken by the formula:
0.5[C(rU / rS)]Zand calculate the quantity, in mg, of amitriptyline (C20H23N) in the portion of Tablets taken by the formula:
(277.40/313.86)[(0.5C)(rU / rS)]Yin which Z denotes chlordiazepoxide; Y denotes amitriptyline hydrochloride; 277.40 is the molecular weight of amitriptyline; 313.86 is the molecular weight of amitriptyline hydrochloride; C is the concentration, in µg per mL, of USP Reference Standard in the Standard preparation; and rU and rS are the peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information Please check for your question in the FAQs before contacting USP.
USP35NF30 Page 2617Pharmacopeial Forum: Volume No. 27(6) Page 3263